Skip to main content
logo
Biotest Aktiengesellschaft (ETR:BIO3)
Germany flag Germany · Delayed Price · Currency is EUR
28.40
-1.00 (-3.40%)
Jun 6, 2025, 5:10 PM CET

ETR:BIO3 Revenue

Biotest Aktiengesellschaft had revenue of 124.20M EUR in the quarter ending March 31, 2025, a decrease of -42.29%. This brings the company's revenue in the last twelve months to 635.20M, down -18.83% year-over-year. In the year 2024, Biotest Aktiengesellschaft had annual revenue of 726.20M with 6.08% growth.

Revenue (ttm)
635.20M
Revenue Growth
-18.83%
P/S Ratio
2.18
Revenue / Employee
254.59K
Employees
2,495
Market Cap
1.39B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024726.20M41.60M6.08%
Dec 31, 2023684.60M168.50M32.65%
Dec 31, 2022516.10M500.00K0.10%
Dec 31, 2021515.60M31.40M6.48%
Dec 31, 2020484.20M65.10M15.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bayer Aktiengesellschaft45.87B
Siemens Healthineers AG23.38B
Fresenius SE & Co. KGaA22.45B
Merck KGaA21.27B
Fresenius Medical Care AG19.64B
Sartorius Aktiengesellschaft3.52B
Redcare Pharmacy NV2.82B
Fielmann Group AG2.42B
Revenue Rankings

Biotest Aktiengesellschaft News

More News